Peter Radovich
Vermögen: 5 Mio $ am 31.10.2026
Vermögen: 5 Mio $ am 31.10.2026
Peter Radovich is currently Independent Director at MBX Biosciences, Inc. since 2026 and President & Chief Operating Officer at Mirum Pharmaceuticals, Inc. since 2024.
Former roles include Senior Director & VP-Program Leadership at Onyx Pharmaceuticals, Inc. from 2004 to 2006, Independent Director at Rain Oncology, Inc. from 2018 to 2024, Principal at Chiron Corp.
from 2004 to 2006, Vice President-Global Product Kyprolis at Onyx Pharmaceuticals, Inc. from 2013 to 2014, and Senior Vice President-Operations at Global Blood Therapeutics, Inc. from 2016 to 2020.
Education includes an MBA from the University of Washington and an undergraduate degree from Texas Christian University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 57’260 ( 0.09% ) | 5 Mio $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Präsident | 16.01.2024 |
| MBX BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 20.10.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| RAIN ONCOLOGY INC. | Direktor/Vorstandsmitglied | 25.01.2024 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Geschäftsführer | 01.04.2020 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01.01.2014 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Direktor/Vorstandsmitglied | 01.09.2006 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01.01.2006 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
MBX Biosciences, Inc.
MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen